Author
A.N. Chremos
Also Known As
A N Chremos, A. N. CHREMOS, A. N. Chremos, A.N. Chremos, AN Chremos, Athanassios N Chremos
29
Publications
1K
Citations
19
H-Index
33
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 9 | 9 | 564 |
2 | Public Health | 2 | 2 | 72 |
3 | Epidemiology | 2 | 2 | 72 |
4 | Health Sciences | 1 | 1 | 31 |
5 | Biochemistry | 1 | 1 | 47 |
A.N. Chremos
×
21
Publications
958
Citations
17
H-Index
| Year | Citations | |
|---|---|---|
Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome John M. Howard, A.N. Chremos, Martin J. Collen, MedicinePharmacological AgentClinical PharmacologyZollinger-ellison SyndromePharmacotherapy | 1985 | 186 |
1991 | 110 | |
1992 | 82 | |
1984 | 71 | |
1988 | 51 | |
1987 | 48 | |
1985 | 47 | |
1991 | 41 | |
1986 | 37 | |
1986 | 35 |
Page 1
Page 1